Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / HCV treatment in Sardinian HIV-HCV coinfected patients: a real-life perspective Study on safety, efficacy and immune reconstitution.

< BACK TO ARCHIVE


2022 Sep 29


Expert Rev Anti Infect Ther


http://www.ncbi.nlm.nih.gov/pubmed/36173889?dopt=Abstract

HCV treatment in Sardinian HIV-HCV coinfected patients: a real-life perspective Study on safety, efficacy and immune reconstitution.

Authors

HCV treatment in Sardinian HIV-HCV coinfected patients: a real-life perspective Study on safety, efficacy and immune reconstitution.
Pes F, Onali S, Balestrieri C, Angioni G, Ortu F, Piano P, Lucia B, Scioscia R, Princic E, Bolliri A C, Casale M, Cola A, Conti M, Peddis L, Serra G, Vacca S, Loi M, Urru E, Murru C, Matta L, et al.
Expert Rev Anti Infect Ther. 2022 Sep 29.
PMID: 36173889.

Abstract

HIV-HCV co-infected patients have long been considered difficult-to-treat. The introduction of direct-acting antivirals (DAAs) changed this paradigm.
Read This Paper